Drug Target Review

FEBRUARY 26, 2024

Her research focus is on epigenetic regulation of melanoma and other cancers as well as wound healing, ageing biology and the development of novel epigenetic therapies targeting cancers and skin diseases and she is the owner of 15 issued and pending patents relevant to her research. Dr Alani received her M.D.

Therapies 59

Therapies Molecular Biology Regulations Medical Schools 59

Broad Institute

JANUARY 30, 2024

Bhattacharyya wears many coats today, splitting his time between the Broad and the infectious disease ward at MGH, where a diagnostic method he developed at Broad is now being tested to see if it helps patients quickly receive the best antibiotics for their infections.

Hospitals 137

Hospitals Medical Schools Virus Science 137

Drug Target Review

JUNE 11, 2024

When choosing my bachelor’s degree, the choice was between pursuing a career in biology or in computer science. Biology won that battle, and I pursued a bachelor’s and master’s degree in biochemistry and molecular biology.

Engineering 64

Engineering Science Doctors Molecular Biology 64

Drug Discovery World

NOVEMBER 9, 2023

Thereafter, there will be two presentations, which are: Jan Terje Andersen, PhD, Professor, Department of Pharmacology, University of Oslo; Research Group Leader, Department of Immunology, Oslo University Hospital, on: ‘Biology-based engineering of versatile antibody and albumin technologies’.

Engineering 130

Engineering Therapies Protein Production Science 130

Codon

FEBRUARY 13, 2024

alone, according to the Centers for Disease Control and Prevention. Dr. Jean Paul Pirnay , a senior scientist based at Brussels’ Queen Astrid Military Hospital, has probably used phage therapy more than anyone else in the world outside of the former Soviet Union over the last decade. 4 But the same barriers still exist today.

Therapies 118

Therapies Virus DNA Clinical Trials 118

Codon

JULY 27, 2023

CNGA3-achromatopsia is a hereditary disease that causes people to see in shades of gray. in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. They’re talking about a patient who has a rare genetic disease. From Sulis D.B. in Science. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

CNGA3-achromatopsia is a hereditary disease that causes people to see in shades of gray. in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. They’re talking about a patient who has a rare genetic disease. From Sulis D.B. in Science. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52